Baseline characteristics of the participants and the effects of hyperbaric oxygen therapy
| Case 1 | Case 2 | |
|---|---|---|
| Age (y) | 45 | 56 |
| BMI | 22 | 22 |
| Date of diagnosis (y) | 2021 | 2010 |
| Co-morbidity | None | Chronic kidney disease, asthma, hepatitis B |
| Smoking | Current smoker | Ex-smoker |
| Alcohol consumption | Current drinker | Current drinker |
| NIH classification | IIIA | IIIB |
| NIH-CPSI | ||
| At the baseline | ||
| Pain domain | 4 | 17 |
| Voiding domain | 10 | 7 |
| Quality of life domain | 11 | 10 |
| Overall | 25 | 34 |
| Three months after the baseline | ||
| Pain domain | 0 | 15 |
| Voiding domain | 7 | 6 |
| Quality of life domain | 11 | 10 |
| Overall | 18 | 31 |
| IPSS | ||
| At the baseline | ||
| Voiding symptom | 11 | 8 |
| Storage symptom | 8 | 7 |
| Overall | 19 | 15 |
| Three months after the baseline | ||
| Voiding symptom | 9 | 11 |
| Storage symptom | 5 | 4 |
| Overall | 14 | 15 |
| Overall adverse event | None | None |
BMI: body mass index, NIH: National Institutes of Health, NIH-CPSI: National Institutes of Health-Chronic Prostatitis Symptom Index, IPSS: International Prostate Symptom Score.